16,991 results match your criteria: "Birmingham Women & Children's Hospital[Affiliation]"
Cureus
October 2024
Department of General Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, GBR.
Background Chronic obstructive pulmonary disease (COPD) is a respiratory condition impacting daily activities of susceptible individuals and increasing the risk of respiratory infections and cardiovascular disease. Body Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity (BODE) index is applied clinically to measure the survival of COPD patients. Inflammatory mediators, including cytokines and chemokines, significantly contribute to the COPD pathology.
View Article and Find Full Text PDFJ Womens Health (Larchmt)
January 2025
Department of Obstetrics & Gynecology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Our objective was to investigate patient-reported maternal and perinatal outcomes and survival among women undergoing aortic valve and/or aortic root replacement (AVR/ARR). This was a single-center observational study of U.S.
View Article and Find Full Text PDFParkinsonism Relat Disord
January 2025
Grey Matter Technologies/Modality.ai, San Francisco, CA, USA.
Arch Med Res
November 2024
Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
Menopause
December 2024
Departments of Medicine, Obstetrics and Gynecology, and Epidemiology, University of Michigan, Ann Arbor, MI.
Objective: The aim of this study was to examine how depressive symptoms change in midlife and across the menopause transition.
Methods: We conducted a secondary analysis of data from a prospective population-based cohort, the Coronary Artery Risk Development in Young Adults study. We included women (n = 2,160) with ≥3 responses to the Center for Epidemiologic Studies Depression Scale (CES-D) beginning at examination year 5, at approximately 30 years of age, and again at years 10, 15, 20, 25, 30, and 35 (ages 35 through 60 years).
Lancet Rheumatol
January 2025
Harvard Medical School, Harvard University, Cambridge, MA, USA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA. Electronic address:
Gynecol Oncol
November 2024
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine and Magee-Womens Research Institute and Foundation, Pittsburgh, PA, United States of America; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States of America; Women's Cancer Research Center, Magee-Womens Research Institute and Foundation and Hillman Cancer Center, Pittsburgh, PA, United States of America; Department of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States of America. Electronic address:
Objective: Social determinants of health (SDOH) impact cancer outcomes. The CDC Social Vulnerability Index (SVI) integrates scores for four neighborhood-based SDOH domains (socioeconomic status, household characteristics, minority status, and housing type/transportation) to assess neighborhood social vulnerability (NSV). While NSV has been associated with overall cancer mortality and lung, breast, colon, and endometrial cancer-specific mortality, the relationship between NSV as defined by the SVI and ovarian cancer outcomes remains unknown.
View Article and Find Full Text PDFJAMA Netw Open
November 2024
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
Front Oncol
November 2024
College of Medicine, Howard University, Washington, DC, United States.
Introduction: Since the implementation of the Patient Protection and Affordable Care Act (ACA) and Medicaid expansion, states that adopted the policy have seen reduced uninsured rates. However, it is unclear whether increased healthcare access, particularly for minority and socioeconomically disadvantaged groups, has translated into measurable improvements in health outcomes.
Objective: Our study aims to evaluate the impact of the ACA and Medicaid expansion on breast cancer outcomes in Louisiana, which has implemented the policy, compared to Georgia, which has not, as of 2024.
Front Public Health
November 2024
Centre for Maternal and Child Health Research, School of Health and Psychological Sciences, City, University of London, London, United Kingdom.
medRxiv
October 2024
Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Blood
November 2024
Dana-Farber Cancer Institute, Boston, Massachusetts, United States.
Detection of light chain (LC) monoclonal gammopathies (MG) traditionally relies on serum free LC (FLC) κ, λ, and their ratio (κ/λ) reference ranges based on a mostly White population. We investigated FLC values in a racially diverse population by screening 10,035 individuals for heavy chain MG, identifying 9,028 negative cases whose FLC were measured. Participants included 4,149 from the PROMISE Study (US, n=2,383; South Africa, n=1,766) and 4,879 from the Mass General Brigham Biobank, with 44% self-identifying as Black.
View Article and Find Full Text PDFCureus
October 2024
Ear, Nose and Throat (ENT), University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
Objectives Percutaneous and transcutaneous bone conduction hearing implants are used in various otological conditions. This study aimed to evaluate patient satisfaction with Sophono implants and their long-term surgical outcomes. Methods This retrospective study was conducted at Queen Elizabeth Hospital, Birmingham, between October 2022 and May 2023.
View Article and Find Full Text PDFFront Genet
November 2024
National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
JAMA Netw Open
November 2024
Division of Rheumatology, Department of Internal Medicine, University of Washington, Seattle.
Importance: The Oral Rheumatoid Arthritis Trial Surveillance demonstrated an increased cancer risk among patients with rheumatoid arthritis (RA) taking tofacitinib compared with those taking tumor necrosis factor inhibitors (TNFis). Although international cohort studies have compared cancer outcomes between TNFis, non-TNFi drugs, and Janus kinase inhibitor (JAKis), their generalizability to US patients with RA is limited.
Objective: To assess the comparative safety of TNFis, non-TNFi drugs, and JAKis among US patients with RA (ie, the cancer risk associated with the use of these drugs among these patients).
Rheumatol Adv Pract
November 2024
Department of Rheumatology, Cambridge University Hospitals, Cambridge, UK.
Front Neurol
November 2024
Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States.
[This corrects the article DOI: 10.3389/fneur.2023.
View Article and Find Full Text PDFBMC Psychiatry
November 2024
Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Background: The present study is an intervention-based qualitative study that explores the factors causing depression among antenatal women and analyses coping strategies based on the modified version of the Thinking Healthy Programme (THP) intervention in the urban setting of Lahore, Pakistan.
Methods: An exploratory qualitative evaluation approach was used in the present study. The study comprises four phases, i.
Int Urogynecol J
November 2024
Department Obstetrics and Gynecology, Alpert Medical School at Brown University, Providence, RI, USA.
Introduction And Hypothesis: This manuscript is a part of the International Urogynecology Consultation (IUC) on pelvic organ prolapse (POP) chapter three, committee three, on the impact of lifestyle modifications (i.e., weight loss, treatment of constipation, activity restriction, etc.
View Article and Find Full Text PDFEur J Endocrinol
November 2024
Department of Rheumatology, Amsterdam University Medical Center, Amsterdam 1081HV, The Netherlands.
N Engl J Med
November 2024
From Cleveland Clinic, Cleveland (O.M.W., W.I.S., K.W.); St. Bernards Medical Center and Arrhythmia Research Group, Jonesboro, AR (D.G.N.); the Cardiology Department, European Georges Pompidou Hospital, Paris (E.M.); Cardioangiologisches Centrum Bethanien, Agaplesion Markus Krankenhaus, Frankfurt am Main (B.S.), Catholic Hospital, Sankt Johann Nepomuk, Erfurt (H.E.), and Deutsches Herzzentrum der Charité (DHZC), Campus Benjamin Franklin, Berlin (C.S.) - all in Germany; Iowa Heart Center, West Des Moines (T.H.); Ascension St. Vincent's Medical Center, Jacksonville, FL (S.O.); UPMC Pinnacle, Harrisburg, PA (C.P.); Vanderbilt University, Nashville (A.K.); Phoenix Cardiovascular Research Group, Phoenix AZ (A.S.); South Denver Cardiology, Littleton, CO (S.S.); Grandview Medical Center, Birmingham, AL (J. Osorio); Heart House-Cooper University, Camden, NJ (G.M.); Lindner Center for Research and Education at Christ Hospital, Cincinnati (M.G.); Emory University, Medicine, Atlanta (D.B.D.); St. Vincent Heart Center of Indiana, Indianapolis (J. Olson); the Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (J.E.N.-K.); St. Antonius Hospital, Nieuwegein, the Netherlands (L.V.A.B.); the Population Health Research Institute, Hamilton, ON, Canada (J.S.H.); Brisbane AF Clinic, Greenslopes Private Hospital, Brisbane, QLD, Australia (K.P.P.); Medstar Health Research Institute, Medstar Washington Hospital Center, Washington, DC (F.M.A.); Boston Scientific, Marlborough, MA (K.R., T.C., B.S.S., K.M.S.); and Cardiac Electrophysiology, Mount Sinai Fuster Heart Hospital School of Medicine, New York (V.Y.R.).
Background: Oral anticoagulation is recommended after ablation for atrial fibrillation among patients at high risk for stroke. Left atrial appendage closure is a mechanical alternative to anticoagulation, but data regarding its use after atrial fibrillation ablation are lacking.
Methods: We conducted an international randomized trial involving 1600 patients with atrial fibrillation who had an elevated score (≥2 in men and ≥3 in women) on the CHADS-VASc scale (range, 0 to 9, with higher scores indicating a greater risk of stroke) and who underwent catheter ablation.
N Engl J Med
November 2024
From Murdoch Children's Research Institute, Melbourne, VIC, Australia (R.S., S.R.); Hospital Vithas Vitoria, Vitoria-Gasteiz (J.M.D.B.), Hospital Universitario Virgen de la Victoria, Malaga (B.D., A.L.-G.), and Hospital Universitario La Paz, Madrid (M. Salcedo) - all in Spain; Sheffield Children's NHS Foundation Trust, Sheffield (P.A.), Birmingham Women's and Children's NHS Foundation Trust, Birmingham (V.S.), NHS Greater Glasgow and Clyde, Glasgow (H.M.), Manchester University NHS Foundation Trust, Manchester (M. Skae), University Hospitals Bristol and Weston NHS Foundation Trust, Bristol (T.C.), and Guy's and St. Thomas' NHS Foundation Trust, London (M.I.) - all in the United Kingdom; Hôpital des Enfants-Toulouse, Toulouse (J.P.S.), Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon (M.N., M.R.), and Hôpital Necker-Enfants Malades, Paris (V.C.-D.) - all in France; the University of Alberta-Stollery Children's Hospital, Edmonton, Canada (P.K.); Vanderbilt University Medical Center, Nashville (J.P.); Cincinnati Children's Hospital Medical Center, Cincinnati (H.S.); Benioff Children's Hospital Oakland, Oakland (P.H.), and BridgeBio Pharma, San Francisco (D.H., E.M., R.W., Y.B., D.R.) - both in California; and Johns Hopkins University, Baltimore (J.H.-F.).
Ultrasound
October 2024
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.